Antimicrobial resistance of respiratory pathogens in North African countries

A Benouda1, S Ben Redjeb, A Hammami

  • 1Laboratoire de Microbiologie, Hôpital Universitaire International Cheikh Zaid - Rabat - Morocco.

Insights

Antimicrobial resistance is high in North Africa. Penicillin non-susceptible Streptococcus pneumoniae strains were common, alongside resistance in Haemophilus influenzae and Streptococcus pyogenes, impacting respiratory tract infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Respiratory tract infections pose a significant public health challenge globally.
  • Antimicrobial resistance (AMR) is a growing threat, necessitating continuous surveillance.
  • Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes are key respiratory pathogens.

Purpose of the Study:

  • To determine the antimicrobial resistance patterns of S. pneumoniae, H. influenzae, and S. pyogenes in North Africa.
  • To assess the susceptibility of these pathogens to commonly used antibiotics.
  • To provide data for guiding antimicrobial therapy in the region.

Main Methods:

  • Collection of 672 non-duplicate bacterial isolates from patients in Algeria, Morocco, and Tunisia between May 2006 and May 2007.
  • Determination of Minimum Inhibitory Concentrations (MICs) using the E-test method.
  • Interpretation of MICs according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines.

Main Results:

  • 47% of Streptococcus pneumoniae isolates were penicillin non-susceptible (PNSP), with 3% showing high resistance.
  • Decreased susceptibility was observed for amoxicillin (20.4%) and cefotaxime (17.4%) in S. pneumoniae.
  • 30.1% of S. pneumoniae exhibited dual resistance to penicillin and erythromycin; most isolates were susceptible to levofloxacin.
  • 13.3% of Haemophilus influenzae isolates were amoxicillin-resistant and beta-lactamase producers.
  • All H. influenzae isolates remained susceptible to cefixime, cefotaxime, and levofloxacin.
  • All Streptococcus pyogenes isolates were susceptible to beta-lactams, but 5.7% showed erythromycin resistance.
  • Five S. pyogenes isolates had decreased susceptibility to levofloxacin.

Conclusions:

  • High prevalence of penicillin non-susceptible Streptococcus pneumoniae strains in North African countries.
  • Significant antimicrobial resistance observed in key respiratory pathogens, necessitating updated treatment guidelines.
  • The study highlights the urgent need for regional AMR surveillance programs to combat resistance trends.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...